Back to Authors

Dale, Stephen

https://orcid.org/0009-0002-1113-7136

A5017119249 | I4210153819

Mayo Clinic

Kura Oncology (United States)

Citations 2

P504: UPDATED DATA FOR ZIFTOMENIB IN PATIENTS WITH NPM1-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e19161da

10.1097/01.hs9.0000968924.19161.da

Update on a Phase 1/2 First-in-Human Study of the Menin-KMT2A (MLL) Inhibitor Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 153-156

10.1182/blood-2022-167412